The first Vincerx Pharma trade was made in Q1 2021.
Since then Ken Griffin bought shares four more times and sold shares on eight occasions. The investor completely sold their stake between Q1 2024 and Q3 2024.
Avg closing price
Price range
Sold -8.91 Thousand shares
Q3 2024
Avg closing price
$13.72
Price range
$10.28
-
$16.78
Sold 9.7% shares (-955 shares)
Q1 2024
Avg closing price
$63.20
Price range
$21.40
-
$161.20
Increased shares by 16.9% (+1.43 Thousand shares)
Q4 2023
Avg closing price
$16.80
Price range
$12.50
-
$23.60
Sold 74.4% shares (-24.6 Thousand shares)
Q3 2023
Avg closing price
$19.40
Price range
$13.20
-
$27.60
Increased shares by 5.9% (+1.83 Thousand shares)
Q2 2023
Avg closing price
$28.61
Price range
$17.60
-
$38.00
Sold 0.3% shares (-81 shares)
Q4 2022
Avg closing price
$18.83
Price range
$12.87
-
$26.50
Increased shares by 0.3% (+82 shares)
Q3 2022
Avg closing price
$28.77
Price range
$20.60
-
$34.40
Sold 0.1% shares (-21 shares)
Q2 2022
Avg closing price
$44.47
Price range
$25.80
-
$78.60
Sold 0.1% shares (-17 shares)
Q1 2022
Avg closing price
$123.52
Price range
$79.00
-
$208.80
Sold 0.2% shares (-72 shares)
Q4 2021
Avg closing price
$249.53
Price range
$189.60
-
$339.00
Sold 1.6% shares (-497 shares)
Q3 2021
Avg closing price
$291.71
Price range
$232.00
-
$347.80
Increased shares by 47.9% (+10.3 Thousand shares)
Q2 2021